Week of February 18 - 24, 2018


Apalutamide (Erleada ™)

Apalutamide (Erleada ™) is an androgen receptor inhibitor indicated for the treatment of non-metastatic castration resistant prostate cancer. 

Diarrhea After Radiaion

Some people develop ongoing diarrhea, incontinence, and urgency when the bowel is in the radiation treatment area.

Tisagenlecleucel (Kymriah ™)

Tisagenlecleucel (Kymriah ™) is a CD19-directed genetically-modified autologous (self-directed) T cell immunotherapy cancer treatment used in the treatment of acute lymphoblastic leukemia. 

Axicabtagene Ciloleucel (Yescarta ™)

Axicabtagene Ciloleucel (Yescarta ™) is a CD19-directed genetically-modified autologous (self-directed) T cell immunotherapy cancer treatment used in the treatment of some types of non-Hodgkin lymphoma.  

Trastuzumab-dkst (Ogivri)

Trastuzumab-dkst (Ogivri) is a biosimilar monoclonal antibody used in the treatment of some types of breast and gastric cancers. 

Biosimilars

In formation about biosimilars - a biologic medication that is almost an exact copy of another medication.

Osteoradionecrosis

Osteoradionecrosis (ORN) is a possible side effect of radiation treatment for head and neck cancers. 

All About COBRA

Provides a brief overview of COBRA and how it can assist with maintaining health insurance coverage after a change in employment status.

Blogs

The Conception of OncoLink – A Perspective
by Carolyn Vachani, MSN, RN, AOCN
March 1, 2012

“No Shave November”
by Angelo Melendez
November 10, 2016
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
R
S
T
U
V
X
Y
Z
#
 
A
B
C
E
G
H
K
L
M
N
O
P
R
S
T
U
 
 
 
 
Stay informed with the latest information from OncoLink!   Subscribe to OncoLink eNews
View our newsletter archives